ESC 365 - Q&A

Open Access

Q&A

Session: Why does an expanding data and product portfolio position lytic-free thrombectomy as the first choice for acute pulmonary embolism (PE) treatment?

Topic: Acute Pulmonary Embolism

Sponsored by Inari Medical

Event: ESC Congress 2023

Congress Presentation

Add to my library

3 more presentations in this session

Risk stratification of intermediate risk pulmonary embolism: importance of normotensive shock

Speaker: Professor S. Bangalore (New York, US)

New datasets impacting the status quo of the treatment of intermediate-high pulmonary embolism patients- FLASH, PEERLESS and PEERLESS II

Speaker: Professor F. Mahfoud (Basel, CH)

How does FLAME data improve the management of high-risk pulmonary embolism patients?

Speaker: Doctor C. Toma (Pittsburgh, US)

Access the full session

Why does an expanding data and product portfolio position lytic-free thrombectomy as the first choice for acute pulmonary embolism (PE) treatment?

Speakers: Professor S. Bangalore, Professor F. Mahfoud, Doctor C. Toma

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources